Skip to main content

Table 1 Patient Characteristics and Lung Functions

From: Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis

  IPF Sar CVD-IP HV
Male/female 18/1 3/3 3/6 6/0
Age
(range)
67.0 ± 1.9
(48-83)
58.5 ± 23.2
(24-76)
59.4 ± 14.8
(33-76)
N.D.
(20-24)
Smoker 16* 6* 3 0
PaO2/FIO2 372 ± 9.2
(307-453)
419 ± 29
(319-529)
358 ± 23
(278-448)
N.D.
%VC 62 ± 4.6
(33-110)
101 ± 6.1#
(83-120)
67 ± 6.6
(43-98)
N.D.
DLCO/VA 4.0 ± 0.2
(2.6-5.4)
4.8 ± 0.4
(4.1-6.3)
7.1 ± 1.9
(4.4-14.0)
N.D.
  1. IPF, idiopathic pulmonary fibrosis; Sar, sarcoidosis; CVD-IP, collagen vascular disease with interstitial pneumonia; HV, healthy volunteers; N.D, not determined; DLco, single-breath carbon monoxide diffusing capacity; VA, alveolar ventilation per minute
  2. Age data and lung function parameters are shown as mean ± SEM.
  3. *p < 0.001 v. s. HV
  4. §p < 0.001 v. s. CVD-IP, p < 0.005 v. s. CVD-IP
  5. #p < 0.0005 vs. IPF